July 28, 2022 | Monkeypox (MPV) Info & Vaccination Locations | Symptoms | Appointments | Criteria | Lakeview Northalsted Chicago
The Chicago Department of Public Health (CDPH) recently announced a list of official community partners residents can contact for the MPV vaccine. Not all listed community partners will have available doses or open appointments, so many are now offering waitlists. Chicago will be receiving an increasing number of doses in the coming weeks.
Currently to qualify for the vaccine you must fulfill one of the below eligibility criteria:
If you meet the eligibility criteria then you can call any of the following vaccine providers to check vaccine availability:
You can also sign up online with the following partners:
The Ruth M. Rothstein CORE Center, 2020 W Harrison, click here.
Esperanza Health Centers, 2001 S California Ave., Suite 100, click here.
University of Illinois – Project WISH, 840 S Wood St., click here.
For the most up-to-date information please visit Chicago.Gov/Monkeypox.
MPV is a viral infection transmitted through close contact. The strain of MPV located in Chicago is different from the strain seen on many news platforms, and takes more forms than severe, swollen pox. Common symptoms include rash, pimples or unusual sores, fever, chills, fatigue, head or muscle aches, or swelling of the lymph nodes.
To date, most Chicago cases have been identified in individuals that have experienced skin-to-lesion contact and/or sexual contact with men who have sex with men (MSM).
With Market Days 2022 fast approaching, if you experience any of the symptoms listed above, please immediately consult with a medical provider to test, and take steps to isolate and prevent the spread of MPV.
Northalsted also encourages all those planning to work at and/or attend Market Days to get their COVID-19 Booster Shots if you have not done so already.
All those who are above the age of 18 are recommended to get the first COVID-19 Booster shot at least 5 months after their second shot, and those who are over 50 as well as all 18+ individuals who are immunocompromised are recommended to get the second COVID-19 Booster at least 4 months after their first booster.